Clinical Trials Browser

Therapeutics × Other hematologic neoplasm × 90 days × Clear all

NCT07301424 2026-05-06

Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL

Phase 2 Not yet recruiting

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07526597 2026-04-13

STOP-CLL-DCT

Phase 2 Not yet recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell